This sale reduced Chemours to 25.1% of Luminus’ reportable 13F assets under management. Top holdings after the filing: NYSE:CC: $27.96 million (25.1% of AUM) NYSE:OI: $26.53 million (23.8% of AUM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback